Stocktoria

Nutex Health Inc. NUTX

Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2011-03-18

Nutex Health Inc. financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$875.3M$479.9M$247.6M$219.3M$331.5M
Gross profit$444.3M$196.3M$34.8M$15.4M$179.3M
R&D expense$285,880
Operating income$275.6M$130.7M-$31.8M-$406.6M$170.3M
Interest expense$16.3M$12.5M$6.2M
Income tax$64.4M$15.0M-$5.1M$13.1M$965,731
Net income$70.8M$52.1M-$45.8M-$424.8M$132.6M
EPS (diluted)$10.48$9.69$-10.39$-100.36$0.22
Operating cash flow$248.1M$23.2M$1.3M$50.6M$173.4M
Free cash flow$245.6M$20.8M-$8.2M$36.0M$136.5M
Cash & equivalents$185.6M$40.6M$22.0M$34.3M$36.1M
Inventory$2.9M$2.9M$3.4M$3.5M$2.8M
Total assets$918.5M$655.3M$398.2M$431.8M$394.7M
Total liabilities$495.1M$466.8M$319.1M$311.4M$203.1M
Shareholders' equity$423.4M$188.5M$79.1M$120.3M$191.6M

Source: SEC EDGAR filings · CIK 0001479681 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.